DIAGNOSIS OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA
Keywords:
diagnostics, hepatocellular carcinoma, fibrolamellar variant, hepatic adenoma, immunohistochemistry.Abstract
Summary. Diagnosis of the fibrolamellar variant of hepatocellular carcinoma (FL-HCC), causes difficulties
in practical medicine. Based on this, the article gives an
overview of modern methods of diagnostics of PL-HCC,
morphological characteristics of this variant of cancer,
description of its typical immunophenotype, as well as
criteria of differential diagnosis, describes own experience of diagnostics of FL-HCC in a patient of 1999 year
of birth.
References
Hamilton S, Aaltonen L. Pathology and genetics of tumours of the digestive system. Geneva: World Health Organization, 2000.
Chagas A, Kikuchi L, Herman P, et al. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases. Clinics 2015; 70 (3): 207–13.
Castro-Villabón D, Barrera-Herrera L, Rodríguez-Urrego P, et al. Hepatocellular carcinoma with both fibrolamellar and classical components: an unusual morphological pattern. Case Rep Pathol 2015; 2015: 1–5.
Bosman F. WHO classification of tumours of the digestive system. Lyon: IARC, 2010.
Pawlik T, Lafaro K. Fibrolamellar hepatocellular carcinoma: current clinical perspectives. J Hepatocellular Carcinoma
; 2: 151–7.
Kassahun W. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome,
prognostic factors, and recent developments. World J Surg Oncol 2016; 14 (1): 151.
Choi W, Ramachandran R, Kakar S. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Human Pathol 2017; 63: 1–13.
Sergi C. Hepatocellular carcinoma, fibrolamellar variant: diagnostic pathologic criteria and molecular pathology update. A primer. Diagnostics 2015; 6 (1): 3.
Kanel G, Korula J. Atlas of liver pathology. Philadelphia, Pa.: Elsevier/Saunders, 2011.
Choi W, Kakar S. Immunohistochemistry in the diagnosis of hepatocellular carcinoma. Gastroenterol Clin North Am 2017; 46 (2): 311–25.
Nguyen T, Roncalli M, Di Tommaso L, Kakar S. Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma. Modern Pathol 2016; 29 (3): 283–92.
